Transcriptomics

Dataset Information

0

A Safety and Efficacy Study of ChAd63/MVA METRAP + RTS,S


ABSTRACT: The goal of this phase 1/2a sporozoite challenge trial (NCT01883609) was to evaluate novel malaria vaccination regimens of the GSK pre-erythrocytic RTS,S/AS01B vaccine alone and concomitantly same-site administered with the viral vectors ChAd63 & MVA encoding the liver stage antigen construct ME-TRAP. Four vaccine groups were studied and received three vaccinations at a monthly interval. All subjects then underwent controlled human malaria infection (CHMI) 11 weeks after first vaccine administration.

ORGANISM(S): Homo sapiens

PROVIDER: GSE103862 | GEO | 2020/09/01

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2020-09-01 | GSE103874 | GEO
2012-12-01 | GSE30564 | GEO
2012-12-01 | E-GEOD-30564 | biostudies-arrayexpress
2017-04-27 | E-MTAB-4629 | biostudies-arrayexpress
2021-06-05 | GSE176156 | GEO
2020-05-13 | GSE144826 | GEO
2020-04-21 | GSE102288 | GEO
2020-04-21 | GSE107672 | GEO
2020-10-30 | E-MTAB-9642 | biostudies-arrayexpress
2022-08-20 | GSE211599 | GEO